Menu Search
Equities

Touyun Biotech Group Ltd

1332:HKG.HS

Touyun Biotech Group Ltd

Actions
  • Price (HKD)0.17
  • Today's Change-0.005 / -2.86%
  • Shares traded110.00k
  • 1 Year change-64.95%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in HKDIncome statement in HKDView more

Year on year Touyun Biotech Group Ltd's revenues fell -37.10%from 315.83m to 198.64m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a 35.78% reduction in net income from a loss of 198.07m to a larger loss of 268.94m.
Gross margin32.34%
Net profit margin-139.37%
Operating margin-135.02%
Return on assets-35.67%
Return on equity-335.55%
Return on investment-97.59%
More ▼

Cash flow in HKDView more

In 2023, cash reserves at Touyun Biotech Group Ltd fell by 93.61m. However, the company earned 3.65m from its operations for a Cash Flow Margin of 1.84%. In addition the company used 70.95m on investing activities and also paid 27.68m in financing cash flows.
Cash flow per share-0.0689
Price/Cash flow per share--
Book value per share-0.0166
Tangible book value per share-0.0166
More ▼

Balance sheet in HKDView more

Touyun Biotech Group Ltd has a Debt to Total Capital ratio of 107.00%, a lower figure than the previous year's 114.68%.
Current ratio0.3392
Quick ratio0.3063
Total debt/total equity--
Total debt/total capital1.07
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.